| Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 KL Ong, LK Stafford, SA McLaughlin, EJ Boyko, SE Vollset, AE Smith, ... The Lancet 402 (10397), 203-234, 2023 | 1760 | 2023 |
| Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 BS Sheena, L Hiebert, H Han, H Ippolito, M Abbasi-Kangevari, ... The lancet Gastroenterology & hepatology 7 (9), 796-829, 2022 | 514 | 2022 |
| Global, regional, and national burden of osteoarthritis, 1990–2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021 JD Steinmetz, GT Culbreth, LM Haile, Q Rafferty, J Lo, KG Fukutaki, ... The Lancet Rheumatology 5 (9), e508-e522, 2023 | 465 | 2023 |
| Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in … AJ Ferrari, DF Santomauro, A Aali, YH Abate, C Abbafati, H Abbastabar, ... The Lancet 403 (10440), 2133-2161, 2024 | 420 | 2024 |
| Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 JD Steinmetz, KM Seeher, N Schiess, E Nichols, B Cao, C Servili, ... The Lancet Neurology 23 (4), 344-381, 2024 | 388 | 2024 |
| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 377 | 2024 |
| Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 R Sharma, M Abbasi-Kangevari, R Abd-Rabu, H Abidi, E Abu-Gharbieh, ... The lancet Gastroenterology & hepatology 7 (7), 627-647, 2022 | 367 | 2022 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 258 | 2024 |
| The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019 EM Alvarez, LM Force, R Xu, K Compton, D Lu, HJ Henrikson, ... The Lancet Oncology 23 (1), 27-52, 2022 | 178 | 2022 |
| Effects of crocin in reducing DNA damage, inflammation, and oxidative stress in multiple sclerosis patients: A double‐blind, randomized, and placebo‐controlled trial M Ghiasian, F Khamisabadi, N Kheiripour, M Karami, R Haddadi, ... Journal of Biochemical and Molecular Toxicology 33 (12), e22410, 2019 | 76 | 2019 |
| Silymarin improved 6-OHDA-induced motor impairment in hemi-parkisonian rats: behavioral and molecular study R Haddadi, AM Nayebi, S Farajniya, SE Brooshghalan, H Sharifi DARU Journal of Pharmaceutical Sciences 22, 1-9, 2014 | 52 | 2014 |
| Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019 D Wu, Y Jin, Y Xing, MD Abate, M Abbasian, M Abbasi-Kangevari, ... EClinicalMedicine 64, 2023 | 49 | 2023 |
| RETRACTED: Silymarin prevents apoptosis through inhibiting the Bax/caspase-3 expression and suppresses toll like receptor-4 pathway in the SNc of 6-OHDA intoxicated rats R Haddadi, AM Nayebi, SE Brooshghalan Biomedicine & Pharmacotherapy 104, 127-136, 2018 | 46 | 2018 |
| Pre-treatment with silymarin reduces brain myeloperoxidase activity and inflammatory cytokines in 6-OHDA hemi-parkinsonian rats R Haddadi, AM Nayebi, SE Brooshghalan Neuroscience Letters 555, 106-111, 2013 | 42 | 2013 |
| Silymarin and neurodegenerative diseases: Therapeutic potential and basic molecular mechanisms R Haddadi, Z Shahidi, S Eyvari-Brooshghalan Phytomedicine 79, 153320, 2020 | 41 | 2020 |
| Effects of vitamin D in an animal model of Alzheimer’s disease: Behavioral assessment with biochemical investigation of Hippocampus and serum N Mehri, R Haddadi, M Ganji, S Shahidi, S Soleimani Asl, ... Metabolic brain disease 35, 263-274, 2020 | 39 | 2020 |
| Gastrodin microinjection suppresses 6-OHDA-induced motor impairments in parkinsonian rats: insights into oxidative balance and microglial activation in SNc R Haddadi, M Poursina, F Zeraati, F Nadi Inflammopharmacology 26, 1305-1316, 2018 | 35 | 2018 |
| In vivo efficacy of 3D‐printed elastin–gelatin–hyaluronic acid scaffolds for regeneration of nasal septal cartilage defects A Shokri, K Ramezani, MR Jamalpour, C Mohammadi, F Vahdatinia, ... Journal of Biomedical Materials Research Part B: Applied Biomaterials 110 (3 …, 2022 | 32 | 2022 |
| Indomethacin loaded dextran stearate polymeric micelles improve adjuvant-induced arthritis in rats: design and in vivo evaluation AR Abdollahi, F Firouzian, R Haddadi, A Nourian Inflammopharmacology 29, 107-121, 2021 | 32 | 2021 |
| In vitro wound healing activity of Scrophularia striata hydroalcoholic extract R Haddadi, P Tamri, FJ Jooni South African Journal of Botany 121, 505-509, 2019 | 30 | 2019 |
Professor S. FarajniaTabriz University of Medical sciencesAdresse e-mail validée de tbzmed.ac.ir
